In a report released today, Dewey Steadman from Canaccord Genuity maintained a Hold rating on TLTeligent Inc (NASDAQ: TLGT), with a price target of $4. The company’s shares opened today at $4.12.
According to TipRanks.com, Steadman is a 3-star analyst with an average return of 3.6% and a 40.2% success rate. Steadman covers the Healthcare sector, focusing on stocks such as ANI Pharmaceuticals Inc, Pacira Pharmaceuticals, and Perrigo Company plc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for TLTeligent Inc with a $4.50 average price target.
See today’s analyst top recommended stocks >>
Based on TLTeligent Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $20.72 million. In comparison, last year the company had a GAAP net loss of $919K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.
